Zions Bancorporation, National Association ZION
Composite 64/100; the shares have moved about 23% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 49/100 — a slight mark against it.
Valuation ranks 79/100 — a strong point in its favour. Income ranks 72/100 — a moderate point in its favour. Momentum ranks 71/100 — a moderate point in its favour.
Growth ranks 49/100 — a slight mark against it.
What the company does Zions Bancorporation provides commercial and small business banking, investment banking, and related financial services across 11 western states through brands such as Zions Bank and Amegy Bank. Its offerings include lending, deposit products, cash management, and capital markets services for businesses and municipalities.
Key financials The bank reports strong profitability with ROE at 16.4% and ROA at 1.3%, alongside net margins of 31.8%. Revenue grew 35.2% and EPS surged 87.1%, supported by a high Sideravia Quality score of 75.2 and Growth score of 86.4.
Stock health Momentum is positive with 12-month returns of 30.91% and a 6-month gain of 20.85%, though it remains 5.29% below its 52-week high. The Sideravia Overall score is 71.8, reflecting strong quality, valuation, and income metrics.
Price vs fair value The stock trades at a discount to both our fair-value estimate and analyst target: - Price is trading at a discount of 26.90% versus our fair-value estimate of 88.17 - Price is trading at a discount of 7.91% versus the analyst 12-month target of 74.95 - High profitability (ROE 16.4%) and growth (EPS 87.1%) support valuation - Valuation percentile of 73.5/100 indicates attractive pricing relative to peers - Dividend yield of 2.6% with a conservative payout ratio of 22.9% adds income appeal
Looking forward Forward P/E of 11.10 suggests moderate earnings expectations, while the Sideravia Valuation score of 73.5 supports the discount. Momentum remains positive, but near-term upside may be tempered by the 5.29% gap to the 52-week high.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.